Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Meijer GJ"" wg kryterium: Autor


Tytuł:
Factors Associated with Esthetic Outcomes of Flapless Immediate Placed and Loaded Implants in the Maxillary Incisor Region-Three-Year Results of a Prospective Case Series.
Autorzy:
Groenendijk E; Private Clinic for Oral Implantology & Reconstructive Dentistry, Implantologie Den Haag BV, Stadhouderslaan 12, 2517 HW The Hague, The Netherlands.
Staas TA; Private Dental Clinic, Staas & Bergmans Zorg Voor uw Mond, Schubertsingel 32, 5216 XA Den Bosch, The Netherlands.
Bronkhorst EM; Radboud Institute of Health Sciences, Department of Dentistry, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Raghoebar GM; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
Meijer GJ; Department of Oral and Maxillofacial Surgery, Radboudumc, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2023 Mar 31; Vol. 12 (7). Date of Electronic Publication: 2023 Mar 31.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Correction: A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE).
Autorzy:
van Goor IWJM; Department of Surgery, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands. .; Department of Radiation Oncology, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands. .
Daamen LA; Department of Surgery, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands.; Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
Besselink MG; Department of Surgery, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.
Bruynzeel AME; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Department of Radiation Oncology, Amsterdam University Medical Center, location Vrije Universiteit, Amsterdam, the Netherlands.
Busch OR; Department of Surgery, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.
Cirkel GA; Department of Medical Oncology, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands.
Koerkamp BG; Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.
Mohammed NH; Department of Medical Oncology, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands.
Heerkens HD; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
van Laarhoven HWM; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Department of Medical Oncology, Amsterdam University Medical Center, location University of Amsterdam, Amsterdam, the Netherlands.
Meijer GJ; Department of Radiation Oncology, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands.
Nuyttens J; Department of Radiation Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.
van Santvoort HC; Department of Surgery, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands.
van Tienhoven G; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Department of Radiation Oncology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Verkooijen HM; Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
Wilmink JW; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Department of Medical Oncology, Amsterdam University Medical Center, location University of Amsterdam, Amsterdam, the Netherlands.
Molenaar IQ; Department of Surgery, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands.
Intven MPW; Department of Radiation Oncology, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands. .
Pokaż więcej
Corporate Authors:
Dutch Pancreatic Cancer Group
Źródło:
Trials [Trials] 2023 Jan 24; Vol. 24 (1), pp. 55. Date of Electronic Publication: 2023 Jan 24.
Typ publikacji:
Published Erratum
Tytuł:
A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE).
Autorzy:
van Goor IWJM; Department of Surgery, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands. .; Department of Radiation Oncology, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands. .
Daamen LA; Department of Surgery, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands.; Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
Besselink MG; Department of Surgery, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.
Bruynzeel AME; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Department of Radiation Oncology, Amsterdam University Medical Center, location Vrije Universiteit, Amsterdam, the Netherlands.
Busch OR; Department of Surgery, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Amsterdam, the Netherlands.
Cirkel GA; Department of Medical Oncology, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands.
Groot Koerkamp B; Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.
Haj Mohammed N; Department of Medical Oncology, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands.
Heerkens HD; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
van Laarhoven HWM; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Department of Medical Oncology, Amsterdam University Medical Center, location University of Amsterdam, Amsterdam, the Netherlands.
Meijer GJ; Department of Radiation Oncology, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands.
Nuyttens J; Department of Radiation Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.
van Santvoort HC; Department of Surgery, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands.
van Tienhoven G; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Department of Radiation Oncology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Verkooijen HM; Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
Wilmink JW; Cancer Center Amsterdam, Amsterdam, the Netherlands.; Department of Medical Oncology, Amsterdam University Medical Center, location University of Amsterdam, Amsterdam, the Netherlands.
Molenaar IQ; Department of Surgery, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands.
Intven MPW; Department of Radiation Oncology, Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands. .
Pokaż więcej
Corporate Authors:
Dutch Pancreatic Cancer Group
Źródło:
Trials [Trials] 2022 Oct 28; Vol. 23 (1), pp. 913. Date of Electronic Publication: 2022 Oct 28.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Radiosurgery*/adverse effects
Pancreatic Neoplasms*/radiotherapy
Pancreatic Neoplasms*/surgery
Carcinoma, Pancreatic Ductal*/radiotherapy
Carcinoma, Pancreatic Ductal*/surgery
Humans ; Retrospective Studies ; Prospective Studies ; Quality of Life ; Pituitary Adenylate Cyclase-Activating Polypeptide ; Neoplasm Recurrence, Local/pathology ; Pancreatic Neoplasms
Czasopismo naukowe
Tytuł:
Online adaptive MR-guided stereotactic radiotherapy for unresectable malignancies in the upper abdomen using a 1.5T MR-linac.
Autorzy:
Daamen LA; Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center & St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands.; Department of Radiation Oncology, UMC Utrecht Cancer Center, Utrecht University, Utrecht, The Netherlands.
de Mol van Otterloo SR; Department of Radiation Oncology, UMC Utrecht Cancer Center, Utrecht University, Utrecht, The Netherlands.
van Goor IWJM; Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center & St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands.; Department of Radiation Oncology, UMC Utrecht Cancer Center, Utrecht University, Utrecht, The Netherlands.
Eijkelenkamp H; Department of Radiation Oncology, UMC Utrecht Cancer Center, Utrecht University, Utrecht, The Netherlands.
Erickson BA; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Hall WA; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Heerkens HD; Department of Radiation Oncology, UMC Utrecht Cancer Center, Utrecht University, Utrecht, The Netherlands.
Meijer GJ; Department of Radiation Oncology, UMC Utrecht Cancer Center, Utrecht University, Utrecht, The Netherlands.
Molenaar IQ; Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center & St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands.
van Santvoort HC; Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center & St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands.
Verkooijen HM; Division of Imaging, UMC Utrecht Cancer Center, Utrecht University, Utrecht, The Netherlands.
Intven MPW; Department of Radiation Oncology, UMC Utrecht Cancer Center, Utrecht University, Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 Jan; Vol. 61 (1), pp. 111-115. Date of Electronic Publication: 2021 Dec 08.
Typ publikacji:
Journal Article
MeSH Terms:
Abdominal Neoplasms*
Radiosurgery*/adverse effects
Radiotherapy, Image-Guided*
Abdomen ; Humans ; Prospective Studies ; Radiotherapy Planning, Computer-Assisted
Czasopismo naukowe
Tytuł:
Tumor volume regression during neoadjuvant chemoradiotherapy for esophageal cancer: a prospective study with weekly MRI.
Autorzy:
Defize IL; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Boekhoff MR; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Borggreve AS; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
van Lier ALHMW; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Takahashi N; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Haj Mohammad N; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Ruurda JP; Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
van Hillegersberg R; Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Mook S; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Meijer GJ; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2020 Jul; Vol. 59 (7), pp. 753-759. Date of Electronic Publication: 2020 May 13.
Typ publikacji:
Journal Article
MeSH Terms:
Tumor Burden*/drug effects
Tumor Burden*/radiation effects
Adenocarcinoma/*therapy
Esophageal Neoplasms/*therapy
Esophageal Squamous Cell Carcinoma/*therapy
Adenocarcinoma/diagnostic imaging ; Adenocarcinoma/secondary ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carboplatin/administration & dosage ; Dose Fractionation, Radiation ; Esophageal Neoplasms/diagnostic imaging ; Esophageal Neoplasms/pathology ; Esophageal Squamous Cell Carcinoma/diagnostic imaging ; Esophageal Squamous Cell Carcinoma/secondary ; Female ; Humans ; Lymphatic Metastasis ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoadjuvant Therapy ; Paclitaxel/administration & dosage ; Prospective Studies ; Time Factors
Czasopismo naukowe
Tytuł:
Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study.
Autorzy:
Borggreve AS; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. .; Department of Surgical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. .
Mook S; Department of Surgical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Verheij M; Department of Radiation Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Mul VEM; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GW, Groningen, The Netherlands.
Bergman JJ; Department of Gastroenterology, Amsterdam University Medical Centers, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Bartels-Rutten A; Department of Radiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Ter Beek LC; Department of Radiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Beets-Tan RGH; Department of Radiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Bennink RJ; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
van Berge Henegouwen MI; Department of Surgical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Brosens LAA; Department of Pathology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Defize IL; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.; Department of Surgical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
van Dieren JM; Department of Gastroenterology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Dijkstra H; Department of Radiology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GW, Groningen, The Netherlands.
van Hillegersberg R; Department of Surgical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Hulshof MC; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
van Laarhoven HWM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Lam MGEH; Department of Nuclear Medicine, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
van Lier ALHMW; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Muijs CT; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GW, Groningen, The Netherlands.
Nagengast WB; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GW, Groningen, The Netherlands.
Nederveen AJ; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Noordzij W; Department of Nuclear Medicine, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GW, Groningen, The Netherlands.
Plukker JTM; Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GW, Groningen, The Netherlands.
van Rossum PSN; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Ruurda JP; Department of Surgical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
van Sandick JW; Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Weusten BLAM; Department of Gastroenterology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Voncken FEM; Department of Radiation Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Yakar D; Department of Radiology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GW, Groningen, The Netherlands.
Meijer GJ; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Pokaż więcej
Corporate Authors:
PRIDE study group
Źródło:
BMC cancer [BMC Cancer] 2018 Oct 20; Vol. 18 (1), pp. 1006. Date of Electronic Publication: 2018 Oct 20.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Observational Study
MeSH Terms:
Chemoradiotherapy/*methods
Esophageal Neoplasms/*diagnostic imaging
Esophageal Neoplasms/*therapy
Neoadjuvant Therapy/*methods
Positron Emission Tomography Computed Tomography/*methods
Preoperative Care/*methods
Esophageal Neoplasms/epidemiology ; Follow-Up Studies ; Humans ; Treatment Outcome
Czasopismo naukowe
Tytuł:
DW-MRI and DCE-MRI are of complementary value in predicting pathologic response to neoadjuvant chemoradiotherapy for esophageal cancer.
Autorzy:
Heethuis SE; a Department of Radiotherapy , University Medical Center Utrecht , Utrecht , Netherlands.
Goense L; a Department of Radiotherapy , University Medical Center Utrecht , Utrecht , Netherlands.; b Department of Surgery , University Medical Center Utrecht , Utrecht , Netherlands.
van Rossum PSN; a Department of Radiotherapy , University Medical Center Utrecht , Utrecht , Netherlands.
Borggreve AS; a Department of Radiotherapy , University Medical Center Utrecht , Utrecht , Netherlands.; b Department of Surgery , University Medical Center Utrecht , Utrecht , Netherlands.
Mook S; a Department of Radiotherapy , University Medical Center Utrecht , Utrecht , Netherlands.
Voncken FEM; c Department of Radiotherapy , The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital , Amsterdam , Netherlands.
Bartels-Rutten A; d Department of Radiology , The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital , Amsterdam , Netherlands.
Aleman BMP; c Department of Radiotherapy , The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital , Amsterdam , Netherlands.
van Hillegersberg R; b Department of Surgery , University Medical Center Utrecht , Utrecht , Netherlands.
Ruurda JP; b Department of Surgery , University Medical Center Utrecht , Utrecht , Netherlands.
Meijer GJ; a Department of Radiotherapy , University Medical Center Utrecht , Utrecht , Netherlands.
Lagendijk JJW; a Department of Radiotherapy , University Medical Center Utrecht , Utrecht , Netherlands.
van Lier ALHMW; a Department of Radiotherapy , University Medical Center Utrecht , Utrecht , Netherlands.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2018 Sep; Vol. 57 (9), pp. 1201-1208. Date of Electronic Publication: 2018 May 21.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study
MeSH Terms:
Chemoradiotherapy*
Contrast Media*/analysis
Diffusion Magnetic Resonance Imaging*
Esophageal Neoplasms/*diagnosis
Esophageal Neoplasms/*therapy
Magnetic Resonance Imaging/*methods
Adenocarcinoma/diagnosis ; Adenocarcinoma/pathology ; Adenocarcinoma/therapy ; Adult ; Aged ; Esophageal Neoplasms/pathology ; Female ; Humans ; Male ; Middle Aged ; Neoadjuvant Therapy ; Predictive Value of Tests ; Prognosis ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies